APA (7th ed.) Citation

Reustle, A., Di Marco, M., Meyerhoff, C., Nelde, A., Walz, J. S., Winter, S., . . . Stevanović, S. (2020). Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy. Genome Medicine, 12(1), 1. https://doi.org/10.1186/s13073-020-00731-8

Chicago Style (17th ed.) Citation

Reustle, Anna, et al. "Integrative -omics and HLA-ligandomics Analysis to Identify Novel Drug Targets for CcRCC Immunotherapy." Genome Medicine 12, no. 1 (2020): 1. https://doi.org/10.1186/s13073-020-00731-8.

MLA (9th ed.) Citation

Reustle, Anna, et al. "Integrative -omics and HLA-ligandomics Analysis to Identify Novel Drug Targets for CcRCC Immunotherapy." Genome Medicine, vol. 12, no. 1, 2020, p. 1, https://doi.org/10.1186/s13073-020-00731-8.